Cleared Traditional

K961511 - HAPSET HYDROXYLAPATITE BONE GRAFT PLASTER

K961511 is an FDA 510(k) clearance for HAPSET HYDROXYLAPATITE BONE GRAFT PLASTER, manufactured by Lifecore Biomedical, Inc.. The device is a Class 2 General & Plastic Surgery device with product code LZK cleared through the Traditional 510(k) pathway after a 70-day FDA review.

K961511 · Lifecore Biomedical, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1996
Decision
70d
Days
Class 2
Risk

K961511 is an FDA 510(k) clearance for the HAPSET HYDROXYLAPATITE BONE GRAFT PLASTER. Classified as Implant, Malar (product code LZK), Class II - Special Controls.

Submitted by Lifecore Biomedical, Inc. (Chaska, US). The FDA issued a Cleared decision on June 28, 1996 after a review of 70 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.3550 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Lifecore Biomedical, Inc. devices

FDA 510(k) Submission Details - K961511

510(k) Number K961511 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 1996
Decision Date June 28, 1996
Days to Decision 70 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 115d · This submission: 70d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LZK Device Classification - Class 2, Special Controls

Product Code LZK Implant, Malar
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.3550
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - LZK Implant, Malar

All 32
Devices cleared under the same product code (LZK) and FDA review panel - the closest regulatory comparables to K961511.
BONE SOURCE HYDROXYAPATITE
K970400 · Orthofix, Inc. · May 1997
SURGIFORM ANATOMICAL MALAR
K964443 · Surgical Technology Laboratories, Inc. · Dec 1996
IMPLANTECH WM NASAL-LABIAL IMPLANT
K962261 · Implantech Associates, Inc. · Aug 1996
SAM FACIAL IMPLANT
K961210 · W.L. Gore & Associates, Inc. · Jun 1996
MEDIAL MALAR IMPLANT
K961080 · Rand Scientific Corp. · Apr 1996
PERMAMESH-D HYDROXYLAPATITE MATRIX
K960354 · Ceramed Corp. · Mar 1996